{"id":"tp-58335","type":"article-newspaper","title":"NervGen Pharma’s Net Loss Rises 36% to C$6.4 Million","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/58335","datePublished":"2026-11-16T12:45:09.000Z","dateModified":"2026-11-16T12:45:09.000Z","language":"en","abstract":"Research and development expenses rose 84% to C$7.9 million, while general and administrative expenses increased 154% to C$3.3 million.","section":"Business","references":[]}